Filing Details
- Accession Number:
- 0001127602-20-017999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-27 16:12:52
- Reporting Period:
- 2020-05-22
- Accepted Time:
- 2020-05-27 16:12:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1608822 | Iii J. Peter Valenti | 250 Campus Drive Marlborough MA 01752 | Division Pres., Breast Health | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-22 | 10,493 | $26.21 | 70,484 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-22 | 10,493 | $51.82 | 59,991 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-05-22 | 10,493 | $0.00 | 10,493 | $26.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,493 | 2015-11-07 | 2024-11-07 | No | 4 | M | Direct |
Footnotes
- Includes 20,644 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $51.79 to $51.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of share sold at each price.